NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 68 filers reported holding NATERA INC in Q1 2016. The put-call ratio across all filers is 18.79 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $748,000 | +13.3% | 16,929 | +23.2% | 0.00% | 0.0% |
Q2 2023 | $660,000 | -12.9% | 13,741 | +1.0% | 0.00% | -50.0% |
Q1 2023 | $758,000 | +30.2% | 13,606 | -5.6% | 0.00% | +100.0% |
Q4 2022 | $582,000 | -18.4% | 14,418 | -11.8% | 0.00% | -50.0% |
Q3 2022 | $713,000 | -9.6% | 16,341 | -27.4% | 0.00% | 0.0% |
Q2 2022 | $789,000 | +7.3% | 22,511 | +24.4% | 0.00% | 0.0% |
Q1 2022 | $735,000 | -57.5% | 18,094 | -2.2% | 0.00% | -50.0% |
Q4 2021 | $1,729,000 | -4.2% | 18,508 | +14.0% | 0.00% | -20.0% |
Q3 2021 | $1,804,000 | +28.1% | 16,232 | +30.8% | 0.01% | +25.0% |
Q2 2021 | $1,408,000 | +41.4% | 12,410 | +27.6% | 0.00% | +33.3% |
Q1 2021 | $996,000 | +114.2% | 9,724 | -80.6% | 0.00% | -25.0% |
Q1 2018 | $465,000 | +3.3% | 50,115 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $450,000 | -30.3% | 50,115 | 0.0% | 0.00% | -33.3% |
Q3 2017 | $646,000 | +18.8% | 50,115 | 0.0% | 0.01% | +20.0% |
Q2 2017 | $544,000 | +22.5% | 50,115 | 0.0% | 0.01% | +25.0% |
Q1 2017 | $444,000 | -24.4% | 50,115 | 0.0% | 0.00% | -33.3% |
Q4 2016 | $587,000 | +5.6% | 50,115 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $556,000 | -8.1% | 50,115 | -0.2% | 0.01% | -25.0% |
Q2 2016 | $605,000 | +29.6% | 50,200 | +2.3% | 0.01% | +300.0% |
Q1 2016 | $467,000 | – | 49,080 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |